10Y UST4.77%-0.42%30Y MTG6.71%+0.75%SOFR3.65%-0.27%VNQ$96.27+0.26%XLRE$44.08+0.34%FED FUNDS3.63%
Real Estate Trail
Institutional Press Wire
PR Newswire · Land

Central Admixture Pharmacy Services Announces Sale of 503B Product Portfolio to Quva Pharma

Via PR Newswire · September 8, 2026
Compiled by Real Estate Trail Editorial · September 8, 2026

Why this matters

Land continues to behave as the highest-conviction long-duration bet in CRE. In supply-constrained luxury markets, replacement-cost-positive entitlements remain scarce; in growth-corridor exurbs, sponsors with patient capital are accumulating positions ahead of the next residential or industrial pipeline. The trade is a basis call, not an income call, and continues to attract family-office and high-net-worth capital that can hold through the cycle.

Editorial analysis · Real Estate Trail Editorial

On the RET wire

Computed from Real Estate Trail’s own tracked coverage

Excerpt from PR Newswire:
Quva and CAPS collaborate to maintain supply of critical medications to U.S. hospitals. SUGAR LAND, Texas and ALLENTOWN, Pa., Sept. 8, 2026 /PRNewswire/ -- QuVa Pharma, Inc. ("Quva") and Central Admixture Pharmacy Ser…
Read the full article at PR Newswire

External link. Real Estate Trail does not republish source content.

Related coverageLand